3rd International Targeted Focal Therapy in Prostate Cancer
Friday, January 29, 2010

Cascade Conference Center
Vail, Colorado

Click on the Presentations to Download PDFs

Why There is a Demand for Targeted Focal Therapy:
Proposed Selection Criteria: PART 1 | Part 2 | Part 3
E. David Crawford, MD – Denver, Colorado

What is "Insignificant Cancer?"
Pathological Issues and the Role of Prostate Mapping
M. Scott Lucia, MD – Denver, CO

VTP in the Treatment of Localized Prostate Cancer
Frans M. J. Debruyne, MD, PhD – Arnhem, The Netherlands

Abalation Modalities for Prostate Cancer:
Cryoablation and the COLD (Cryo On-Line Data) Registry
J. Stephen Jones, MD – Cleveland, Ohio

PCA3 Clinical Trial Results
Adrie van Bokhoven, PhD – Denver, Colorado